Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants.
D000328:Adult; D000818:Animals; D001279:Atracurium; D001341:Autonomic Nervous System / Q000187:drug effects; D002415:Cats; D002648:Child; D004305:Dose-Response Relationship, Drug; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007223:Infant; D007546:Isoquinolines / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D009125:Muscle Relaxants, Central / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D009466:Neuromuscular Blocking Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D010197:Pancuronium / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D014673:Vecuronium Bromide
D007546:Isoquinolines; D009125:Muscle Relaxants, Central; D009466:Neuromuscular Blocking Agents; D001279:Atracurium; D014673:Vecuronium Bromide; D010197:Pancuronium